DrugsNews.net

Drugs Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Cardiobase

Search results for "Jardiance"

The European Commission has granted marketing authorisation for Empagliflozin ( Jardiance ), a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor. Empagliflozin has been approved for the treatment of ...


The FDA ( Food and Drug Administration ) Advisory Committee has voted 12-11 that substantial evidence exists to establish that Jardiance ( Empagliflozin ) reduces cardiovascular death in adults with t ...


The FDA ( Food and Drug Administration ) has approved a new indication for Jardiance ( Empagliflozin ) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established ...